Prospective Coronary Heart Disease Cohort
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorShandong First Medical University
About this trial
To evaluate the biomarkers for the prognosis of coronary heart disease, patients with coronary heart disease will be recruited and followed up for at least 2 years.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Diagnosed as coronary heart disease or with unexplained chest pain needed to undergo coronary angiography.
Healthy subjects undergoing routine physical examination in the physical examination department and willing to sign informed consent will be recruited as control subjects.
Disqualifiers
With malignant tumors, infectious diseases and advanced liver diseases.
Won't sign an inform consent.
Trial population
Patients with coronary heart diseases undergoing coronary angiography and healthy control subjects undergoing routine physical examination in physical examination department.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
major adverse cardiovascular events
all-cause mortality, cardiovascular mortality, ischemic stroke, heart failure and rehospitalization
Time frame
2-year outcome and long-term outcomeSponsors and contacts
Click on the lead sponsor to view all of their trials.
Shandong First Medical University
Lead sponsor
Jinan Central Hospital
Collaborator
Shandong Provincial Hospital
Collaborator
The Second Affiliated Hospital of Shandong First Medical University
Collaborator
Qianfoshan Hospital
Collaborator
Source ClinicalTrials.gov